Abstract:BACKGROUND:The majority of published article on cardiopulmonary resuscitation(CPR) used healthy animals. In fact,patients commonly have severe heart diseases before CPR,leading to ventricular fibrillation. OBJECTIVE:To investigate outcome of myocardial function and cardiopulmonary resuscitation in myocardial infarction rats treated with bone marrow mesenchymal stem cells(MSCs) transplantation. DESIGN,TIME AND SETTING:A randomized,controlled animal experiment was performed at the University of Southern California and Second Hospital of Sun Yat-sen University from April to August 2007. MATERIALS:A total of 18 adult male SD rats were randomly divided into model control and cell transplantation groups with 9 animals in each group. In addition,1 SD rat aged 1 month was used to prepare bone marrow MSCs. METHODS:Myocardial ischemia was induced by ligation of the left anterior descending artery(LAD) . Animals respectively received 5×106 MSCs(0.1 mL) marked with PKH26 in phosphate buffer solution(PBS) or PBS alone 4 weeks after LAD ligation. Ventricular fibrillation and CPR were performed 4 weeks after MSCs or PBS injection. MAIN OUTCOME MEASURES:Heart function was evaluated by ultrasound cardiography 2,4 weeks after transplantation;hemodynamics was measured before and 4 hours following CPR. Myocardial tissues were harvested 72 hours after CPR for pathological exanimation. RESULTS:Compared with model control group,ejection fraction of transplantation group was significantly increased 2 and 4 weeks after transplantation(P < 0.01) ,and cardiac index,dp/dt40,and-dp/dt were significantly improved before and within 4 hours after CPR(P < 0.01,P < 0.05) . Moreover,the rats survived longer in transplantation group(72 hours) after CPR compared with control group(P < 0.05) . Pathological section results showed a large number of PKH26-labeled MSCs in the myocardium. CONCLUSION:Myocardial function,hemodynamics and survival time after CPR were significantly improved in animals treated with MSCs transplantation.

Cardiopulmonary resuscitation in myocardial infarction rats treated with bone marrow mesenchymal stem cell transplantation